GB0507811D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB0507811D0
GB0507811D0 GB0507811A GB0507811A GB0507811D0 GB 0507811 D0 GB0507811 D0 GB 0507811D0 GB 0507811 A GB0507811 A GB 0507811A GB 0507811 A GB0507811 A GB 0507811A GB 0507811 D0 GB0507811 D0 GB 0507811D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0507811A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Camurus AB
Original Assignee
Camurus AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Camurus AB filed Critical Camurus AB
Priority to GB0507811A priority Critical patent/GB0507811D0/en
Publication of GB0507811D0 publication Critical patent/GB0507811D0/en
Priority to NZ551990A priority patent/NZ551990A/en
Priority to SG2011047453A priority patent/SG173326A1/en
Priority to EP05749850A priority patent/EP1768650B1/en
Priority to CA2569513A priority patent/CA2569513C/en
Priority to MXPA06014095A priority patent/MXPA06014095A/es
Priority to US11/628,007 priority patent/US8236292B2/en
Priority to CN200580021940.8A priority patent/CN101014319B/zh
Priority to AU2005249274A priority patent/AU2005249274B2/en
Priority to CN2010102495161A priority patent/CN102008728B/zh
Priority to ES05749850T priority patent/ES2309766T3/es
Priority to AT05749850T priority patent/ATE401054T1/de
Priority to PL05749850T priority patent/PL1768650T3/pl
Priority to DK05749850T priority patent/DK1768650T3/da
Priority to JP2007514136A priority patent/JP5127449B2/ja
Priority to KR1020077000258A priority patent/KR101225257B1/ko
Priority to RU2006146009/15A priority patent/RU2390331C2/ru
Priority to PCT/GB2005/002217 priority patent/WO2005117830A1/en
Priority to BRPI0511807A priority patent/BRPI0511807C8/pt
Priority to DE602005008247T priority patent/DE602005008247D1/de
Priority to EP09014796A priority patent/EP2206495B1/en
Priority to PL05818606T priority patent/PL1845942T3/pl
Priority to CA2594710A priority patent/CA2594710C/en
Priority to AU2005324794A priority patent/AU2005324794C1/en
Priority to ES05818366T priority patent/ES2363419T3/es
Priority to KR1020077018617A priority patent/KR100983746B1/ko
Priority to CA2594718A priority patent/CA2594718C/en
Priority to JP2007550827A priority patent/JP5107725B2/ja
Priority to DK05818606.5T priority patent/DK1845942T3/da
Priority to EP05818366A priority patent/EP1843746B1/en
Priority to AT05818337T priority patent/ATE462409T1/de
Priority to PCT/GB2005/004752 priority patent/WO2006075125A1/en
Priority to SI200531846T priority patent/SI1845942T1/sl
Priority to PCT/GB2005/004746 priority patent/WO2006075123A1/en
Priority to DE602005020359T priority patent/DE602005020359D1/de
Priority to PCT/GB2005/004748 priority patent/WO2006075124A1/en
Priority to US11/795,242 priority patent/US8920782B2/en
Priority to ES05818606.5T priority patent/ES2458992T3/es
Priority to US11/795,249 priority patent/US8871712B2/en
Priority to JP2007550826A priority patent/JP5171262B2/ja
Priority to ES05818337T priority patent/ES2343641T3/es
Priority to PL05818337T priority patent/PL1848403T3/pl
Priority to EP05818606.5A priority patent/EP1845942B1/en
Priority to EP05818337A priority patent/EP1848403B8/en
Priority to AT05818366T priority patent/ATE501710T1/de
Priority to DE602005026998T priority patent/DE602005026998D1/de
Priority to CA2594711A priority patent/CA2594711C/en
Priority to JP2007550825A priority patent/JP5144277B2/ja
Priority to PL05818366T priority patent/PL1843746T3/pl
Priority to US11/795,250 priority patent/US9757461B2/en
Priority to ES09014796T priority patent/ES2400034T3/es
Priority to PL09014796T priority patent/PL2206495T3/pl
Priority to IL179815A priority patent/IL179815A/en
Priority to US11/798,495 priority patent/US8236755B2/en
Priority to AU2010202794A priority patent/AU2010202794B2/en
Priority to US13/537,096 priority patent/US8545832B2/en
Priority to JP2012156518A priority patent/JP5731446B2/ja
Priority to US13/558,463 priority patent/US20130190341A1/en
Priority to US14/017,823 priority patent/US20140193347A1/en
Priority to US14/138,704 priority patent/US9649382B2/en
Priority to US14/143,665 priority patent/US20140219935A1/en
Priority to US14/486,035 priority patent/US20150064118A1/en
Priority to US14/551,761 priority patent/US9968680B2/en
Priority to US15/653,993 priority patent/US20180078647A1/en
Priority to US16/030,697 priority patent/US20180311163A1/en
Priority to US16/947,934 priority patent/US20210128473A1/en
Priority to US17/731,534 priority patent/US20230027339A1/en
Ceased legal-status Critical Current

Links

GB0507811A 2003-11-07 2005-04-18 Formulation Ceased GB0507811D0 (en)

Priority Applications (67)

Application Number Priority Date Filing Date Title
GB0507811A GB0507811D0 (en) 2005-04-18 2005-04-18 Formulation
NZ551990A NZ551990A (en) 2004-06-04 2005-06-06 Liquid depot formulations
SG2011047453A SG173326A1 (en) 2004-06-04 2005-06-06 Liquid depot formulations
EP05749850A EP1768650B1 (en) 2004-06-04 2005-06-06 Liquid depot formulations
CA2569513A CA2569513C (en) 2004-06-04 2005-06-06 Preformulation for liquid crystalline phase structure
MXPA06014095A MXPA06014095A (es) 2004-06-04 2005-06-06 Formulaciones de deposito de lipidos.
US11/628,007 US8236292B2 (en) 2004-06-04 2005-06-06 Liquid depot formulations
CN200580021940.8A CN101014319B (zh) 2004-06-04 2005-06-06 液体贮库制剂
AU2005249274A AU2005249274B2 (en) 2004-06-04 2005-06-06 Liquid depot formulations
CN2010102495161A CN102008728B (zh) 2004-06-04 2005-06-06 液体贮库制剂
ES05749850T ES2309766T3 (es) 2004-06-04 2005-06-06 Formulaciones liquidas de liberacion lenta.
AT05749850T ATE401054T1 (de) 2004-06-04 2005-06-06 Flüssige depotformulierungen
PL05749850T PL1768650T3 (pl) 2004-06-04 2005-06-06 Ciekłe formulacje depot
DK05749850T DK1768650T3 (da) 2004-06-04 2005-06-06 Flydende depotformuleringer
JP2007514136A JP5127449B2 (ja) 2004-06-04 2005-06-06 流体デポ製剤
KR1020077000258A KR101225257B1 (ko) 2004-06-04 2005-06-06 유동성 데포 제제
RU2006146009/15A RU2390331C2 (ru) 2004-06-04 2005-06-06 Жидкие депо-препараты
PCT/GB2005/002217 WO2005117830A1 (en) 2004-06-04 2005-06-06 Liquid depot formulations
BRPI0511807A BRPI0511807C8 (pt) 2004-06-04 2005-06-06 pré-formulação, processo de formação de uma pré-formulação e uso da mesma
DE602005008247T DE602005008247D1 (de) 2004-06-04 2005-06-06 Flüssige depotformulierungen
EP09014796A EP2206495B1 (en) 2005-01-14 2005-12-09 Topical bioadhesive formulations
PL05818606T PL1845942T3 (pl) 2005-01-14 2005-12-09 Preparaty analogu GnRH
CA2594710A CA2594710C (en) 2005-01-14 2005-12-09 Topical bioadhesive formulations
AU2005324794A AU2005324794C1 (en) 2003-11-07 2005-12-09 Somatostatin analogue formulations
ES05818366T ES2363419T3 (es) 2005-01-14 2005-12-09 Formulaciones de análogos de somatostatina.
KR1020077018617A KR100983746B1 (ko) 2005-01-14 2005-12-09 소마토스타틴 유사 제형
CA2594718A CA2594718C (en) 2005-01-14 2005-12-09 Gnrh analogue formulations
JP2007550827A JP5107725B2 (ja) 2005-01-14 2005-12-09 ＧｎＲＨ類似体製剤
DK05818606.5T DK1845942T3 (da) 2005-01-14 2005-12-09 GNRH-analogformuleringer
EP05818366A EP1843746B1 (en) 2005-01-14 2005-12-09 Somatostatin analogue formulations
AT05818337T ATE462409T1 (de) 2005-01-14 2005-12-09 Topische bioadhäsive formulierungen
PCT/GB2005/004752 WO2006075125A1 (en) 2005-01-14 2005-12-09 GnRH ANALOGUE FORMULATIONS
SI200531846T SI1845942T1 (sl) 2005-01-14 2005-12-09 Gnrh analogne formulacije
PCT/GB2005/004746 WO2006075123A1 (en) 2005-01-14 2005-12-09 Topical bioadhesive formulations
DE602005020359T DE602005020359D1 (de) 2005-01-14 2005-12-09 Topische bioadhäsive formulierungen
PCT/GB2005/004748 WO2006075124A1 (en) 2005-01-14 2005-12-09 Somatostatin analogue formulations
US11/795,242 US8920782B2 (en) 2005-01-14 2005-12-09 Topical bioadhesive formulations
ES05818606.5T ES2458992T3 (es) 2005-01-14 2005-12-09 Formulaciones de análogos de GnRH
US11/795,249 US8871712B2 (en) 2005-01-14 2005-12-09 Somatostatin analogue formulations
JP2007550826A JP5171262B2 (ja) 2005-01-14 2005-12-09 ソマトスタチン類似体製剤
ES05818337T ES2343641T3 (es) 2005-01-14 2005-12-09 Formulaciones bioadhesivas topicas.
PL05818337T PL1848403T3 (pl) 2005-01-14 2005-12-09 Preparaty bioadhezyjne o działaniu miejscowym
EP05818606.5A EP1845942B1 (en) 2005-01-14 2005-12-09 Gnrh analogue formulations
EP05818337A EP1848403B8 (en) 2005-01-14 2005-12-09 Topical bioadhesive formulations
AT05818366T ATE501710T1 (de) 2005-01-14 2005-12-09 Somatostatin-analog-formulierungen
DE602005026998T DE602005026998D1 (de) 2005-01-14 2005-12-09 Somatostatin-analog-formulierungen
CA2594711A CA2594711C (en) 2005-01-14 2005-12-09 Somatostatin analogue formulations
JP2007550825A JP5144277B2 (ja) 2005-01-14 2005-12-09 局所用生体付着性製剤
PL05818366T PL1843746T3 (pl) 2005-01-14 2005-12-09 Formulacje analogów somatostatyny
US11/795,250 US9757461B2 (en) 2005-01-14 2005-12-09 GnRH analogue formulations
ES09014796T ES2400034T3 (es) 2005-01-14 2005-12-09 Formulaciones bioadhesivas tópicas
PL09014796T PL2206495T3 (pl) 2005-01-14 2005-12-09 Bioadhezyjne formulacje do stosowania miejscowego
IL179815A IL179815A (en) 2004-06-04 2006-12-04 Liquids containing low-viscosity non-liquid crystals, their compositions and uses
US11/798,495 US8236755B2 (en) 2004-06-04 2007-05-14 Opioid depot formulations
AU2010202794A AU2010202794B2 (en) 2004-06-04 2010-07-01 Liquid depot formulations
US13/537,096 US8545832B2 (en) 2004-06-04 2012-06-29 Lipid depot formulations
JP2012156518A JP5731446B2 (ja) 2005-01-14 2012-07-12 局所用生体付着性製剤
US13/558,463 US20130190341A1 (en) 2004-06-04 2012-07-26 High bioavailability opioid formulations
US14/017,823 US20140193347A1 (en) 2004-06-04 2013-09-04 Lipid depot formulations
US14/138,704 US9649382B2 (en) 2005-01-14 2013-12-23 Topical bioadhesive formulations
US14/143,665 US20140219935A1 (en) 2005-01-14 2013-12-30 Topical bioadhesive formulations
US14/486,035 US20150064118A1 (en) 2004-06-04 2014-09-15 Lipid depot formulations
US14/551,761 US9968680B2 (en) 2005-01-14 2014-11-24 Topical bioadhesive formulations
US15/653,993 US20180078647A1 (en) 2005-01-14 2017-07-19 Gnrh analogue formulations
US16/030,697 US20180311163A1 (en) 2004-06-04 2018-07-09 Lipid depot formulations
US16/947,934 US20210128473A1 (en) 2004-06-04 2020-08-25 Lipid depot formulations
US17/731,534 US20230027339A1 (en) 2004-06-04 2022-04-28 Lipid depot formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0507811A GB0507811D0 (en) 2005-04-18 2005-04-18 Formulation

Publications (1)

Publication Number Publication Date
GB0507811D0 true GB0507811D0 (en) 2005-05-25

Family

ID=34630868

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0507811A Ceased GB0507811D0 (en) 2003-11-07 2005-04-18 Formulation

Country Status (2)

Country Link
ES (1) ES2363419T3 (es)
GB (1) GB0507811D0 (es)

Also Published As

Publication number Publication date
ES2363419T3 (es) 2011-08-03

Similar Documents

Publication Publication Date Title
ZA200801773B (en) New formulation
GB2424581B (en) Formulations
TWI370115B (en) New formulation
PL1879451T3 (pl) Innowacyjna formulacja
EP1909584A4 (en) PRENYLFLAVONOID FORMULATIONS
GB0608098D0 (en) Formulation
IL191287A0 (en) Atorvastatin formulation
HK1116776A1 (en) Triazolophthalazines as pde2-inhibitors
GB0526419D0 (en) Formulation
GB0517673D0 (en) Formulation
ZA200707654B (en) Formulations
EP1928469A4 (en) Fulvestrant FORMULATION
GB0625312D0 (en) Formulation
GB0625095D0 (en) Formulation
GB0423565D0 (en) Formulation
GB0520176D0 (en) Use
GB0511190D0 (en) Use
GB0412530D0 (en) Formulation
GB0501030D0 (en) Formulation
GB0612809D0 (en) Formulation
GB0502250D0 (en) Use
LT1928232T (lt) Kieta kompozicija
GB0526032D0 (en) Use
GB0526031D0 (en) Use
GB0506035D0 (en) Improved formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)